UBS Group Begins Coverage on MorphoSys (NASDAQ:MOR) : vimars

UBS Group started coverage on shares of MorphoSys (NASDAQ:MOR – Get Rating) in a research note published on Wednesday, The Fly reports. The brokerage issued a buy rating on the stock. MorphoSys Price Performance NASDAQ:MOR opened at $6.58 on Wednesday. The stock has a market cap of $901.00 million, a P/E ratio of -8.12 and […]

Related Keywords

, Nasdaq , Ubs Group , Virtu Financial , Susquehanna International Group , Citadel Advisors , Morphosys Company Profile , Sigma Securities , Get Rating , International Group , Two Sigma Securities , Morphosys Daily , Morphosys , Nasdaq Mor , Humor , Medical , Initiated Coverage , Ubs Group Ag ,